A series of 18 cycloalkyl arylpyrimidines (CAPYs) were designed from lead compounds diarylpyrimidines (DAPYs), synthesized and evaluated for in vitro anti-HIV activity. Among them, the compound 1p displayed potent anti-HIV-1 activity against WT HIV-1 with an EC(50) value of 0.055 μM and a selectivity index (SI) >7290. The preliminary structure-activity relationship (SAR) of this new series of compounds was also investigated, which enriched the SAR of diarylpyrimidines (DAPYs).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2011.10.002 | DOI Listing |
Publication Analysis
Top Keywords
cycloalkyl arylpyrimidines
8
arylpyrimidines capys
8
diarylpyrimidines dapys
8
design synthesis
4
synthesis biological
4
biological evaluation
4
evaluation cycloalkyl
4
capys hiv-1
4
hiv-1 nnrtis
4
nnrtis series
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!